The early onset of peripheral neuropathy might be a robust predictor for time to treatment failure in patients with metastatic breast cancer receiving chemotherapy containing paclitaxel

BACKGROUND: Paclitaxel plays a central role in chemotherapy for breast cancer. Peripheral neuropathy, a well-known toxicity with paclitaxel, may be of interest in predicting the efficacy of paclitaxel therapy for patients with metastatic breast cancer. We performed a retrospective analysis assessing...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:PLoS One
Autors principals: Fukada, Ippei, Ito, Yoshinori, Kobayashi, Kokoro, Shibayama, Tomoko, Takahashi, Shunji, Horii, Rie, Akiyama, Futoshi, Iwase, Takuji, Ohno, Shinji
Format: Artigo
Idioma:Inglês
Publicat: Public Library of Science 2017
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5595337/
https://ncbi.nlm.nih.gov/pubmed/28898275
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0184322
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars